Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Acute Respiratory Distress Syndrome (ARDS): early-phase trial registry
5 of 9 indexed Acute Respiratory Distress Syndrome (ARDS) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 5 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Acute Respiratory Distress Syndrome (ARDS): 9 US clinical trials tracked, 5 recruiting.
Acute Respiratory Distress Syndrome (ARDS) is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is PPD Development, running 4 of these trials.
Enrollment posture brief
Registry condition acute-respiratory-distress-syndrome-ards
OPEN 5 | RECR 56% | LATE 0 | EARLY 6 | RANK #1916 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Advanced Colorectal Cancer (56% recruiting · 9 trials)
Acute Respiratory Distress Syndrome (ARDS) lists 5 open slots (56% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Acute Respiratory Distress Syndrome (ARDS) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Acute Respiratory Distress Syndrome (ARDS) is recruiting above its size-band peers.
5 of 9 indexed trials (55.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Acute Respiratory Distress Syndrome (ARDS) research.
PPD Development accounts for 4 of 9 trials (44.4%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Acute Respiratory Distress Syndrome (ARDS) enrolment sits around 200 participants.
Median target enrolment is 200 among the 9 trials that report a genuine target (sentinel values excluded). 1 of those (11.1%) plan for fewer than 100 participants.
-
Acute Respiratory Distress Syndrome (ARDS) research is mostly interventional.
7 interventional and 2 observational studies make up this index (77.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
PPD Development
NCT06703073
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
PPD Development
NCT06701656
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
PPD Development
NCT06701682
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
PPD Development
NCT06701669
Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial
Children's Hospital of Philadelphia
NCT07123961
An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States
Bayer
NCT06272942
Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS
Aqualung Therapeutics
NCT05938036
The Relationship Between Positive End Expiratory Pressure and Cardiac Index in Patients With Acute Respiratory Distress Syndrome (ARDS) Managed on a Fluid Protocol
Yale University
NCT01714583
Pragmatic Investigation of Volume Targeted Ventilation-1
Wake Forest University Health Sciences
NCT03909854
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 6 |
Top Sponsors
Named interventions
Most-linked intervention names on Acute Respiratory Distress Syndrome (ARDS) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Acute Respiratory Distress Syndrome (ARDS) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Acute Respiratory Distress Syndrome (ARDS) page
9 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Acute Respiratory Distress Syndrome (ARDS) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- PPD Development sponsors the most Acute Respiratory Distress Syndrome (ARDS) trials on record, review their full trial history before evaluating a specific study. See PPD Development's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Respiratory Distress Syndrome (ARDS) condition card totals 9 registered trials; most-linked intervention Cohort C: bevacizumab; top US site state New Jersey. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.